Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH — Stella

Home/Metabolic Dysfunction-Associated Steatotic Liver Disease/

View on ClinicalTrials.gov

Recruiting

Back to Metabolic Dysfunction-Associated Steatotic Liver Disease trials

Trial locations(1 site)

Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Bologna

Key details

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment target

~1,000 participants

Started

November 2024

Primary completion

November 2043

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.